| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EVRI | Common Stock | Sale | -$334K | -14K | -17.72% | $23.86 | 65K | Jul 9, 2021 | Direct | F1, F2 |
| transaction | EVRI | Common Stock | Sale | -$480K | -20K | -30.77% | $24.00 | 45K | Jul 9, 2021 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | The transaction(s) reflected in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on June 9, 2021 for shares purchased on the open market on May 16, 2017 for a price of $6.73. |
| F2 | The price reported in Column 4 of Table I is a weighted average price. The shares were sold in multiple transactions at a price ranging from $23.71 to $24.00. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The transaction(s) reflected in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on June 9, 2021 for shares purchased on the open market on March 12, 2020 for a price of $6.00. |
| F4 | The price reported in Column 4 of Table I is a weighted average price. The shares were sold in multiple transactions at a price of $24.00. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |